FDA says the move boosts regulatory transparency, offering insights into common approval barriers in drug applications and reducing guesswork.

The agency’s Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address ...

Trump’s tax bill could reshape drug R&D, manufacturing, Medicaid access, clinical trials, and biotech funding, impacting ...

The company estimated that more than 1000 women in Scotland at very high risk of fracture would be eligible for treatment.

Two examples of FDA-approved intracameral implants are Durysta (Allergan) and iDoseTR (Glaukos), both of which provide ...

Sascha Berger, private biopharmaceutical investor; Shannon Eaker, CTO of Xcellbio; Edwin Stone, CEO of Cellular Origins; and ...

Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR ...

In contrast to earlier conferences in 2025, experts interviewed as part of the BIO conference in Boston did not come to a ...

Hikma Pharmaceuticals. Hikma Pharmaceuticals USA Announces $1 Billion of New US Investment to Further Expand its Domestic ...

Siemens expands AI-driven pharma software portfolio, integrating Dotmatics’ platform to connect drug research, development, ...

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

The selection of an appropriate salt form for a potential drug candidate is an opportunity to modulate its characteristics to improve bioavailability, stability, manufacturability, and patient ...